Five major genotypes of JC virus (JCV) have been defined based on nucleotide differences in the VP1 gene of the DNA sequence. These types are probably a result of virus evolution in geographically isolated population groups. One of the first genotypes identified, Type 2, was found to represent strains of Asian origin. In order to further define the spectrum within Type 2 strains, the entire 5n1 kb genome of nine urinary strains of JCV was amplified by PCR with one pair of primers. These urine samples were obtained in the USA (California and New Mexico) from three European Americans, three Native Americans, two African Americans and one Hispanic American. The complete genome of an Asian JCV strain (Tokyo-1) isolated from progressive multifocal leukoencephalopathy (PML) brain in
Introduction
JC virus (JCV) is a ubiquitous human polyomavirus which is excreted in the urine of some 40 % of the general population above 30 years of age (Kitamura et al., 1994 ; Agostini et al., 1996 b) . Virus evolution in geographically isolated human populations has generated different genotypes. Five major genotypes have been distinguished in the USA and elsewhere based on partial analysis of the viral genome (Yogo et al., 1991 ; Ault & Stoner, 1992 ; Iida et al., 1993 ; Guo et al., 1996) . Japan was also sequenced. Here, we report the analysis of these ten DNA sequences and their deduced protein translations. Two phylogenetically distinct subtypes of Type 2 were found, 2A and 2B, which differ from each other by 0n8-1n1 % of the coding region sequence. A 215 bp product amplified with primers in the VP1 gene contains enough sequence information to distinguish the major types and subtypes of JCV and is suitable for application in viral epidemiological studies. The investigation of these genomic variations is of special interest because JCV Type 2 strains are found at a significantly higher frequency in brain tissue of patients with PML than would be predicted from their excretion in a control population.
JCV Type 1 is localized in Europe, Type 2 in Asia and Type 3 in Africa . Type 4, found in the USA, is closely related to Type 1, but changes to a Type 3-like sequence within the gene of the major capsid protein VP1, possibly as a result of a recombination event . A strain tentatively assigned as Type 5 (Agostini et al., 1996 b) , has been reassigned as a subtype of Type 3 following complete genome analysis . To date, the major JCV genotypes of the world have also been found in the USA population, but it is likely that additional genotypes remain to be discovered in more isolated indigenous populations. Definition of JCV genotypes on the level of the entire genome will be a useful tool in epidemiological studies and may also illuminate other aspects of virus pathobiology.
Although JCV infects 70-90 % of the population during late childhood and persists in the kidney and possibly other internal organs, the only known illness caused by JCV is the central demyelinating disease, progressive multifocal leuko-encephalopathy (PML). An underlying immunodeficiency favours cytotoxic replication of JCV in oligodendrocytes, the myelin-forming cells. PML is usually fatal within 3-9 months (Walker, 1985) . About 5 % of AIDS patients show neuropathological evidence of PML at autopsy (Kuchelmeister et al., 1993 ; Berger & Concha, 1995) .
JCV was identified in PML brain by electron microscopy in 1965. The prototype JCV strain (Mad1) was isolated from PML brain in 1971 in Madison, WI, USA (Padgett et al., 1971 ; Walker, 1985) . In 1981, a JCV strain known as Tokyo-1 was isolated from PML brain in Japan (Nagashima et al., 1981) . The complete DNA sequence of the JCV (Mad1) genome was reported in 1984 (Frisque et al., 1984) . In 1988, the complete DNA sequence of another isolate from a PML patient, termed GS\B, which differed slightly in sequence from Mad1, was reported in Germany (Loeber & Do$ rries, 1988) .
The circular genome of JCV can be divided into divergently transcribed early and late coding regions and the non-coding control region containing the origin of DNA replication which regulates their transcription. Following early region expression [large T and small t antigens and the newly described Th (Trowbridge & Frisque, 1995) ] and DNA replication, the late proteins consisting of capsid proteins VP1-VP3 and the agnoprotein are synthesized and virions are assembled in the cell nucleus. In PML brain tissue, the regulatory region to the late side of ori shows unique combinations of deletions and duplications which appear to be derived from an archetypal structure persisting in the urinary tract (Yogo et al., 1990 ; Ault & Stoner, 1993) . These rearrangements are independent of the genotypes assigned from the coding region sequence (Iida et al., 1993 ; .
The information about JCV genotypes is based mainly on the VT intergenic region which includes the 3h ends of the genes for VP1 and large T antigen (Ault & Stoner, 1992 ; Iida et al., 1993 ; Guo et al., 1996) , or on type-specific changes within a short VP1 gene fragment located upstream from the VT intergenic region . Whole genome amplification obviates the need to clone directly the low levels of virus found in urine and provides a suitable substrate for direct cycle sequencing of any part of the viral genome. In addition, whole genome amplification followed by direct cycle sequencing provides an averaged sequence at each position, thus eliminating the need for analysis of multiple clones to obtain a sequence representative of the entire virus population. Here, we report amplification of the entire circular viral genome (5n1 kb) of nine urinary strains of JCV in a single PCR by methods previously described . We now report the complete genome DNA sequence of nine Type 2 strains and a tenth sequence which may represent a new genotype most closely related to Type 2B. These ten isolates include nine urinary strains and the JCV (Tokyo-1) strain obtained from the brain of a Japanese PML patient (Nagashima et al., 1981 (Nagashima et al., , 1982 . In order to establish a representative system for the definition of major JCV types and subtypes in clinical samples, sequences obtained were compared with the prototype Type 2 sequence, GS\B, and we show how typing based on the short fragment within the VP1 gene corresponds to phylogenetic relationships based on entire coding region genomes.
Methods
Clinical samples. Urine samples were obtained from individuals in California and New Mexico, USA (three European Americans, two African Americans, three Native Americans and one Hispanic American). The complete JCV genome was amplified from two urine samples collected from the Hispanic American male with multiple sclerosis at different times. Both PCR products were sequenced to confirm the type determination (Type 2A). The carrier of a strain which has not yet been classified, tentatively termed strain X01, was the offspring of an Irish mother and an Italian father. For additional information about the carriers of different strains and their geographical origin see Table 1 .
Unfrozen urine (15-50 ml) was sent to the National Institutes of Health in Bethesda, USA. After centrifugation at 4300 r.p.m. for 10 min, the cell pellet was resuspended in lysis buffer containing 50 mM Tris (pH 8n0), 1 mM EDTA, 0n45 % NP40 and 0n45 % Tween 20, adjusted to pH 8n0, and digested with proteinase K at a final concentration of 0n2 mg\ml. For further details, see previous descriptions by and .
Isolation and cloning of JCV (Tokyo-1). JCV (Tokyo-1) was isolated from the brain of a 70-year-old Japanese patient, who developed PML during the treatment of hepatoma and pulmonary tuberculosis (Nagashima et al., 1982) . The virus was isolated from the autopsy material of the affected part of PML brain (Nagashima et al., 1982) . The virus DNAs were extracted directly from the PML brain or from human foetal glial cells (PHFG) at 6 or 10 passages after inoculation. After digestion with EcoRI they were cloned into the EcoRI site of pUC13. More than 50 clones were isolated and characterized. For this study, we selected the pJCT-TC clone isolated from the PHFG culture. This clone contained the full-length genome and had an identical restriction pattern to the virus DNA which was directly cloned from the PML brain (Matsuda et al., 1987) .
PCR.
For the initial detection of JCV in clinical samples, PCR primers JLP-15 and JLP-16 were used [JLP-15, 5h ACAGTGTGGCCAGAAT-TCCACTACC 3h (1710 -1734 ; JLP-16, 5h TAAAGCCTCCCCCCCA-ACAGAAA 3h (1924 -1902 ; numbering based on JCV (Mad1) (Frisque et al., 1984) ]. A two-step PCR of 30 s at 94 mC and 1 min at 63 mC for 50 cycles amplified a 215 bp fragment from the VP1 gene, which includes the shorter product of 129 bp used for JCV genotyping in earlier work . The entire circular genome of all nine urinary JCV strains was amplified in a single PCR as described previously . Briefly, after BamHI digestion of the JCV genome, primers overlapping the single BamHI site were used to generate a linear 5n1 kb product. The DNA sequence in the region of the BamHI site itself was determined independently following amplification of a separate short PCR fragment spanning the restriction site.
Sequencing of PCR products. Products of three complete genome PCR amplification reactions for each urine sample were combined, gel-purified, and directly cycle sequenced. Primer series JIG-1 to JIG-12 and SEC-1 to SEC-12 were end-labelled with [γ-$$P]ATP (Amersham). The initial denaturation for 1 min at 95 mC was followed by 30 cycles of 30 s at 95 mC for denaturation and 1 min at 65 mC for annealing and elongation. Products were run for 90 or 180 min on a 6 % polyacrylamide gel containing 50 % (w\v) urea (National Diagnostics). Overlapping sequences from both strands were determined. For additional details, see .
Sequencing of JCV (Tokyo-1).
Both strands of the entire sequence of JCV (Tokyo-1) were determined by the dideoxy termination method using T7 Sequenase version 2.0 and [$&S]dATPαS (Amersham). Sequencing primers that did not contain repetitive or complementary structures were utilized. Purified double-stranded DNA of the pJCT-TC clone was used as a template in a single-cycle reaction. Sequence reaction products were electrophoresed using gels composed of 6 % polyacrylamide, 8n3 M urea (50 %) and 1i TBE. Sequence compression and deformity due to secondary structure in the DNA template was resolved using formamide gels composed of 6 % polyacrylamide, 40 % formamide, 7 M urea and 1i TBE. The sequences of both strands were confirmed to be identical.
Computer analysis. Multiple sequences were analysed with the 8-Unix version of the GCG programs (Genetics Computer Group, Madison, WI, USA) on a Silicon Graphics Indigo R4000 computer. Consensus sequences of subtypes 2A and 2B were generated by the Pretty program. Phylogenetic analysis utilized the UPGMA method (Distances and GrowTree programs) with the Jukes-Cantor correction. Design and analysis of primers JIG-1 to JIG-12 and SEC-1 to SEC-12 used the OLIGO program, Version 5.0 (NBI, Plymouth, MN, USA).
Reference sequences. GenBank\EMBL Data Library accession numbers are given in brackets. Archetypal regulatory region : JCV (CY) [M35834] (Yogo et al., 1990 
Results

Subtypes of JCV Type 2
Using the distance matrix analysis of coding region sequences, two subtypes of JCV Type 2, 2A and 2B, can be distinguished. This analysis is based on the entire JCV genome, excluding only the regulatory region to the late side of the origin of replication (ori) [position 1-267, archetypal numbering (Yogo et al., 1990) ]. Strains of JCV Type 2 subtypes 2A and 2B differ by about 0n8-1n1 % as shown in Table 2 . The subtype assignment of strain F230 is uncertain ; the distance matrix shows it to be equidistant from strains of both the 2A and 2B subtypes (0n7-0n9 %), although in the phylogenetic tree it falls into the subtype 2B group (see below). In contrast to the differences between subtypes 2A and 2B ( 1 %), differences between the other major genotypes (Types 1, 3 and 6) are 1n2-2n3 % (Table 3) . Variation between strains within a given subtype is usually less than 0n5 % ( Table 2 ). The Japanese strain JCV (Tokyo-1) is the prototype for subtype 2A whereas the European Type 2 strain JCV(GS\B) is classified as subtype 2B.
Based on the distance matrix calculation for the coding regions of 21 sequences, a phylogenetic tree was generated using the GrowTree program of GCG with the UPGMA method as shown in Fig. 1 . The 21 complete coding regions depicted in the phylogram include previously published JCV (Mad1) (Frisque et al., 1984) and GS\B (Loeber & Do$ rries, 1988) sequences, and the five complete African and African American Type 3 genomes reported previously . In addition, Type 1, Type 4 (F402) and Type 6 sequences are included b ; H. T. Agostini, C. F. Ryschkewitsch & G. L. Stoner, unpublished results). The two subtypes of Type 2 fall into distinct branches of the tree. Strain F230 is associated with the subtype 2B group, but the distance matrix analysis shows that it differs about equally from both subtypes 2A and 2B, so it may represent a new 
* Consensus of six subtype 2A strains. † Consensus of three subtype 2B strains. ‡ A Type 2 strain (this work). § A Type 3 strain . ¶ A Type 6 strain (unpublished data).
subtype distinct from both 2A and 2B (Table 2 ). To date, only this single strain has been observed, and the frequency of these variants in the population is unknown.
Complete genome versus short fragment typing
Complete genome analysis validates the typing assignments based on short DNA fragment amplification (Agostini et al., 1996 b) . The fragment generated by primers JLP-1 and -4 or JLP-15 and -16 (a 129 or 215 bp fragment within the VP1 gene, respectively) allows differentiation of all major genotypes (Types 1-4 and Type 6), and also subtypes of JCV Types 1 and 2 (Agostini et al., 1996 b) . Details of Type 1 subtypes have been described (Agostini et al., 1998 b) . With regard to JCV Type 2, three subtypes 2A, 2B and 2C were initially identified by variations at nucleotide positions 1837 and 1850 (Fig. 2) . Subgroups 2A, 2B and 2C are characterized by nucleotides at positions 1837\1850 of T\A, C\G and T\G, respectively. Although the difference between subtypes 2A and 2B is reflected in the phylogenetic tree analysis (Fig. 1) , the subtype 2C strains which have been completely sequenced fall into either the 2A group (F228, F229) or the 2B group (F230).
The consensus sequence of subtype 2A, which consists of strains F224, F225, F226 and Tokyo-1, differs from that of subtype 2B (strains F223, F227 and GS\B) at a total of 40 positions within the coding region (0n82 %). These sites can be used for subtyping in any region of the genome, and are listed BBEG Definition of JCV Type 2 subtypes Definition of JCV Type 2 subtypes Fig. 1 . Phylogenetic tree of JCV genotypes. The first number in each strain designation stands for the major genotype. Type 2 can be divided into subtypes 2A and 2B. All Native American (F225, F226 and F228) and an Asian strain (Tokyo-1) fall into the Type 2A group, while a European American (F227), an African American (F223) and a European (GS/B) strain fall into the Type 2B group. Two of the strains originally designated Type 2C based on the sequence of the 215 bp VP1 gene fragment fall into the Type 2A group (F228 and F229), while one falls into the Type 2B group (F230). However, strain F230 is clearly distinct from other Type 2B strains and may represent an additional subtype of Type 2. Type 4 (F402) is a variant of the Type 1 genotype, but is distinctive in the 215 bp VP1 gene fragment. Strain X01 is a tentative designation pending additional isolates and its classification as a distinct genotype or as a subtype of Type 2. For origins of strains see Table 1 . For DNA sequences see and the GenBank database.
for reference in Fig. 3 (a) . Also included are comparisons to Type 1 (Agostini et al., 1998 b) and Type 3 (Agostini et al., 1997 a) consensus sequences using JCV (Mad1) numbering (Frisque et al., 1984) .
Variability within the genome
When Type 1, 2 and 3 consensus sequences are compared, the primary sequence varies most within the capsid proteins, especially VP1, and the 3' end of the second exon of large T antigen (data not shown). The agnoprotein gene has very few variations among the three major genotypes . This is in contrast to the relative variation between the consensus sequences of JCV Type 2 subtypes 2A and 2B. With four nucleotide differences in the agnoprotein gene (1n9 %), the relative variability is higher than that between major genotypes (Type 1 vs 2A, 1n4 % ; 1 vs 2B, 0n46%; 1 vs 3, 0n46 % ; 2A vs 3, 0n93 % ; 2B vs 3, 0n93 %). The differences between other genes of the subtype 2A and 2B genomes were lower (VP2, 0n58 % ; VP3, 0n74 % ; VP1, 1n23 % ; T antigen exon 1, 0n41 % ; T antigen exon 2, 0n72 % ; small t antigen, 0n19 %).
The intergenic region between the 3h end of the agnoprotein gene and the start of the VP2 gene is a highly conserved region of the JCV genome. Individual mutations are rare and the consensus sequences of Types 1, 2A, 2B and 3 are identical within this area. An exception is the insertion of a single base pair in this element in strain F224 (see below).
Strain X01
The 30-year-old carrier of strain X01 was born in the USA, the child of an Irish mother and an Italian father. Over the course of 8 months, three urine samples were positive for the same JCV strain. A comparison of the coding region of X01 with Type 1 (Mad1), subtype 2A consensus, subtype 2B consensus and Type 3 (F308) showed that strain X01 differs from Type 1 by 2n05 %, from subtype 2A by 1n33 %, from subtype 2B by 0n81 % and from Type 3 by 1n54 % of the nucleotide sequence (Table 3) . Thus, the status of strain X01 is ambiguous. It could be viewed either as an additional European genotype, or as a new subtype within the Type 2 group which is more closely related to subtype 2B strains than to subtype 2A.
Genotype-related protein changes
As shown in Fig. 3 (b) , the nucleotide differences in JCV subtype 2A and 2B strains result in ten predicted amino acid BBEH H. T. Agostini and others H. T. Agostini and others changes. Again, the highest relative variation in the protein sequence was found in the agnoprotein (3 out of 75 amino acids, i.e. 4 %). In contrast, subtype 2B strains and strain X01 do not differ from each other in the agnoprotein sequence. Two of the predicted changes at positions 59 and 61 are nonconservative changes in which the two neutral amino acids Gln and Thr in subtype 2A are substituted by negatively charged Glu and positively charged Arg in subtype 2B, leaving the overall charge of this highly basic DNA-binding protein unchanged. This is not the case in strain F230 which has a charge change introduced by negatively charged Glu at position 59 and follows the pattern seen in Type 1 and Type 3 strains (Fig. 3 b) . Among Type 2 subtypes and strain X01, the capsid proteins VP2\3 and VP1 show a much higher degree of conservation (Fig. 3 b) .
As discussed previously by , a region of T antigen important for biological function which has sustained mutations during evolution is the zinc finger motif. At position 301, the hydrophobic amino acid residue Leu is found in subtype 2A, Type 3, Type 6 and in strains classified as subtype 2C based on the nucleotide sequence in the VP1 fragment (positions 1710-1924) . In subtype 2B and in strain BBEI Definition of JCV Type 2 subtypes Definition of JCV Type 2 subtypes Fig. 4 . Single nucleotide insertions and deletions. Among the ten strains completely sequenced and reported here, three examples of single base insertions or deletions were found in non-coding regions outside the regulatory region. Top sequence : deoxythymidine is inserted in the intergenic region after position 502 in strain F224 (agnoprotein coding sequence in italics). Bottom sequence : closely related strains F228 and F229 (see Table 2 ) from New Mexico and California both have deoxyadenosine deleted at position 4454 in the large T antigen intron. Dashes indicate identity with the Type 2A sequence. 
* Position of nucleotides based on strain CY (archetype) numbering (Yogo et al., 1990) . Consensus nucleotides are given in the first row and represent the American consensus with A at position 217 (Agostini et al., 1996 b) . -, Identity to consensus. † Genotype assignments based on short typing fragment amplified by primers JLP-15 and -16.
X01, the hydrophilic residue Gln is found at that position, as it is in all Type 1 strains. Another variable site is located in the carboxy terminus of large T antigen at position 653.
Single nucleotide deletions and insertions
The majority of JCV strains analysed do not differ in length from the prototype strain JCV (Mad1) within the overall coding region (4854 bp). However, nucleotide additions or deletions can occur in intergenic regions or in introns which do not affect the reading frame. As shown in Fig. 4 , strain F224 (subtype 2A) has an insertion of deoxythymidine in the agnoprotein-VP2 intergenic region. This insertion was confirmed in multiple PCR amplifications. Two other strains closely related to each other and originally termed subtype 2C (F228 and F229) both have a deletion of deoxyadenosine at position 4454 (Mad1 numbering) (Fig. 4) . Compression artefacts of sequencing have been eliminated as explanations for these deletions by additional sequencing of a short-range amplified product of the large T antigen intron using a different pair of primers (data not shown).
Regulatory region
Of the nine urinary strains sequenced, six had the expected archetypal regulatory region to the right of ori. Details on minor rearrangements in strains F224, F226 and F230 will be published elsewhere. The regulatory region sequences of strains F223 and F227 were identical to the American consensus sequence (Agostini et al., 1996 b) , which differs from the original Asian isolate (Yogo et al., 1990) only at position 217. The usefulness of the regulatory region for subtyping of JCV strains is limited. Previously, deoxyadenosine at position 217 (archetype numbering) (Yogo et al., 1990) seemed to be an exclusive but inconsistent feature of subtype 2A strains, but the unrearranged regulatory region of strain X01 and F230 also show the same nucleotide change. Other point mutations in the regulatory region are listed in Table 4 .
Discussion
This analysis of ten complete JCV genomes confirms the existence of the Type 2 group of sequences and allows the assignment of virus subtypes. These results extend those based on RFLP (Yogo et al., 1991) or partial sequence analysis (Ault & Stoner, 1992 ; Agostini et al., b, 1997 . Here, we have characterized subtypes 2A and 2B, and a possible new subtype represented by strain F230. The first subtype 2A strain was isolated in Japan from a PML brain and termed the Tokyo-1 strain (Nagashima et al., 1981 (Nagashima et al., , 1982 . The subtype 2B prototype was obtained from a PML patient in Germany, and the DNA sequences of both brain and kidney isolates were reported (Loeber & Do$ rries, 1988) . The origins of subtypes 2A and 2B can tentatively be assigned to East Asia and West Asia, respectively, with both genotypes arriving eventually in the USA. Subtype 2A was carried primarily by Native American settlers crossing the Bering land bridge in prehistoric times (Agostini et al., 1997 d) , whereas subtype 2B was probably introduced much later by settlers crossing the Atlantic (see below).
Comparison of the DNA sequence of complete JCV genomes is complicated by the fact that isolates from different PML tissues vary in length due to deletions and duplications occurring in the regulatory region between the origin of DNA replication and the beginning of the agnoprotein gene (Yogo et al., 1990 ; Ault & Stoner, 1993 ; . To circumvent this problem, the analysis of sequence similarity has been limited to 4854 bp [positions 277-5130, JCV (Mad1) BBEJ H. T. Agostini and others H. T. Agostini and others numbering]. Little information is lost as the rearranging portion of the regulatory region contains few typing sites except for deoxycytidine at position 133 in African strains .
The ability to define JCV genotypes and subtypes is important for several reasons. Firstly, identification of typespecific sites allows design of PCR primers for reliable diagnosis of JCV infection in brain biopsies or cerebrospinal fluids. Placement of primers in constant regions of JCV genomes ensures that all genotypes will be amplified equally. It is particularly important that the 3h ends of primers do not coincide with variable, type-determining sites (Ault et al., 1994) .
Secondly, although the full biological significance of JCV coding region genotypes is not yet understood, there is the possibility that nucleotide changes might alter its diseasecausing potential. Indeed, a comparison of the genotype distribution of JCV amplified from the brain of PML patients with that from urine of control individuals revealed that Type 2 strains are more frequent in the brain than in the urinary tract of the control group, suggesting that infection with the Type 2 genotype may be associated with a higher risk of developing PML than infection with JCV strains of other genotypes (Agostini et al., 1997 b) . The increased risk of developing PML associated with Type 2 infection compared with non-Type 2 strains was estimated to be threefold. Subtype analysis of the infecting strains indicated that the numbers of subtype 2A and 2B strains did not increase equally. In fact, the excess was almost entirely due to an increase in the numbers of subtype 2B strains found in PML brains . This finding points toward an unknown factor which differs between Type 2 subtypes and influences the neurotropism and\or neurovirulence of JCV.
Thirdly, genotyping is important for understanding the evolution of JCV within the human population. The origin of JCV genotypes may reflect coevolution of the virus within different lineages of the human family. Genotypes characteristic of Europe (Type 1), Asia (Type 2), and Africa (Type 3) have been described (Yogo et al., 1991 ; Ault & Stoner, 1992 ; Agostini et al., 1996 b ; Guo et al., 1996 ; Stoner et al., 1998) . A second African genotype, Type 6, has been identified in Africa (Guo et al., 1996) and in an African American (H. T. Agostini, C. F. Ryschkewitsch & G. L. Stoner, unpublished results) . It is likely that JCV arrived in the Americas with the ancestors of Native Americans who came across the Bering land bridge from Asia some time between 12 000 and 30 000 years ago. This is supported by the fact that JCV subtype 2A, the most common genotype found in Asia, is also found in a high percentage of modern Native Americans (Agostini et al., 1997 d ) . JCV infection will be useful to follow migration of human populations in more recent times as well, e.g. the migration of Europeans, Africans and Asians to the Americas within the last 500 years. The identification of JCV genotypes appears to provide a quasi-genetic marker which can complement information obtained from the human genome (CavalliSforza et al., 1994) , or from maternally inherited mitochondrial DNA (Vigliant et al., 1989) .
Based on genotyping in a 129 or 215 bp amplified VP1 gene fragment, the Type 2 sequences were first assigned to subgroups 2A, 2B and 2C (Fig. 2) . These subgroups are characterized by nucleotides at positions 1837\1850 of T\A, C\G, and T\G, respectively. Complete genome analysis has established that most of the T\G group (subtype 2C) can be included in subtype 2A on the basis of the complete genome DNA sequence. Two of the three strains in the T\G subgroup (F228 and F229) fell into the subtype 2A group when the entire genome was considered. On the other hand, a third 2C strain, F230, differed by 0n7-0n9 % from both subtypes 2A and 2B, and it may possibly represent a separate and distinct subtype. It is noteworthy that all three original subtype 2C strains (F228, F229, F230) have the nucleotide A at position 3768 which translates as Leu-301 in the zinc finger motif of the large T antigen . This amino acid residue is also found in subtype 2A, Type 3 and Type 6, but not in Type 1, subtype 2B or strain X01, all of which have glutamine. The possibility that this mutation in an essential functional region influences the biological activity of T antigen is currently under investigation.
Rules for assigning JCV genotypes have not yet been defined, but some guidelines can be suggested. Type 1 strains, represented by JCV (Mad1), differ from strains of all other genotypes by about 2n0 % of the genome (Table 3) . Similarly, the African American strain F601, a representative of Type 6, differs from strains of other genotypes by about 2n0 % of its DNA sequence. Types 2 and 3, however, are more closely related, differing from each other by only 1n2-1n3 % (Table 3) . From Table 2 , it is evident that different subtypes of Type 2 (2A, 2B, F230) differ from each other by 0n7-1n1 %. Strain-tostrain variation within the subtypes 2A or 2B is less than 0n5%. As the major JCV genotype differences probably reflect sequence divergence accompanying the human diaspora, it will be of interest to define the remaining extant types and their relationship to indigenous populations of the world.
